Labeler
Amneal Pharmaceuticals LLC NDC Codes
Amneal Pharmaceuticals LLC lists 495 finished drug products in the FDA NDC Directory under NDC labeler codes 60219, 60846, 64896, 65162, 69238, 70121.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Lisdexamfetamine Dimesylate, Valsartan and Hydrochlorothiazide, Lurasidone Hydrochloride, Risperidone, Crexont, Ropivacaine Hydrochloride, Pitavastatin, Pemrydi Rtu, Lyvispah, Cyclophosphamide, Tepadina, Methylene blue, Exenatide, calcium chloride
- Active ingredients
- Isotretinoin, Lisdexamfetamine dimesylate, Valsartan, Hydrochlorothiazide, Lurasidone hydrochloride, Carbidopa hydrate, Levodopa, Ropivacaine hydrochloride, Pitavastatin calcium, Pemetrexed disodium hemipentahydrate, Baclofen, Cyclophosphamide
- NDC labeler codes
- 60219, 60846, 64896, 65162, 69238, 70121
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Methylene blue 5 mg/mL; Exenatide 250 ug/mL; Calcium chloride 100 mg/mL; Valsartan 160 mg/1; Hydrochlorothiazide 25 mg/1; Valsartan 320 mg/1; Medroxyprogesterone acetate 150 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Ropivacaine hydrochloride 5 mg/mL; Ropivacaine hydrochloride 2 mg/mL; Magnesium sulfate heptahydrate 40 mg/mL; Fluorometholone 1 mg/mL; Cyclophosphamide 25 mg/1; Cyclophosphamide 50 mg/1; Lanreotide acetate 120 mg/.5mL; Romidepsin 5 mg/mL; Etoposide 50 mg/1; Denosumab 70 mg/mL; Denosumab 60 mg/mL
- Dosage forms
- Injection, Capsule, Injection, Solution, Tablet, Film coated, Tablet, Extended release, Tablet, Coated, Kit, Capsule, Extended release, Injection, Suspension, Injection, Powder, Lyophilized, For solution, Granule, Tablet, Suspension/ drops, Injection, Solution, Concentrate, Injection, Emulsion, Solution, Tablet, Delayed release, Spray, For solution, Gel
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Epidural, Infiltration, Perineural, Intracavitary, Intravesical, Intra-articular, Intralesional, Intrasynovial, Soft tissue, Ophthalmic, Nasal, Topical
- Drug classes (FDA established)
- Retinoid, Central Nervous System Stimulant, Osmotic Laxative, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Atypical Antipsychotic, Aromatic Amino Acid, Corticosteroid, Amide Local Anesthetic, HMG-CoA Reductase Inhibitor, Potassium Salt, Folate Analog Metabolic Inhibitor, gamma-Aminobutyric Acid-ergic Agonist, RANK Ligand Inhibitor, Alkylating Drug, Oxidation-Reduction Agent, GLP-1 Receptor Agonist, Blood Coagulation Factor, Phosphate Binder, Catechol-O-Methyltransferase Inhibitor, Progestin, Central alpha-2 Adrenergic Agonist, Cytochrome P450 17A1 Inhibitor, Methylxanthine, Calculi Dissolution Agent, Serotonin-1b and Serotonin-1d Receptor Agonist, Somatostatin Analog, Histone Deacetylase Inhibitor, Topoisomerase Inhibitor, Vitamin K, Warfarin Reversal Agent, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, beta-Adrenergic Blocker, Calcitonin, Central Nervous System Depressant, Estrogen Receptor Antagonist, Ergotamine Derivative, Aminosalicylate, Tetracycline-class Drug, Cholinesterase Inhibitor, Proteasome Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Opioid Antagonist, Pyrophosphate Analog DNA Polymerase Inhibitor, Anticholinergic, Cholinergic Muscarinic Antagonist, Sulfone, Hematopoietic Stem Cell Mobilizer, Nucleoside Metabolic Inhibitor
- HCPCS / J-code
- J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J1040 — Injection, methylprednisolone acetate, 80 mg, J1050 — Injection, medroxyprogesterone acetate, 1 mg
- Package NDCs
- 161 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Cyclophosphamide | Cyclophosphamide 25 mg/1 | CapsuleOral | 69238-1561 | 69238-1561-01 | — |
| Cyclophosphamide | Cyclophosphamide 50 mg/1 | CapsuleOral | 69238-1562 | 69238-1562-01 | — |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | 70121-2517 | 70121-2517-05 | — |
| Romidepsin | Romidepsin 5 mg/mL | Injection, Solution, ConcentrateIntravenous | 70121-2250 | 70121-2250-01 | — |
| VePesidetoposide | Etoposide 50 mg/1 | CapsuleOral | 69238-2811 | 69238-2811-02 | — |
| Oziltusdenosumab-mobz | Denosumab 70 mg/mL | Injection, SolutionSubcutaneous | 70121-2701 | 70121-2701-01 | J0897 |
| Boncresadenosumab-mobz | Denosumab 60 mg/mL | Injection, SolutionSubcutaneous | 70121-2702 | 70121-2702-01 | J0897 |
| phytonadione | Phytonadione 1 mg/.5mL | Injection, EmulsionIntramuscular, Intravenous, Subcutaneous | 70121-1682 | 70121-1682-07 | — |
| epinephrine | Epinephrine 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 70121-1660 | 70121-1660-02 | J0171 |
| Isotretinoin | Isotretinoin 20 mg/1 | CapsuleOral | 69238-1255 | 69238-1255-03 | — |
| Isotretinoin | Isotretinoin 10 mg/1 | CapsuleOral | 69238-1254 | 69238-1254-03 | — |
| Isotretinoin | Isotretinoin 40 mg/1 | CapsuleOral | 69238-1259 | 69238-1259-03 | — |
| Isotretinoin | Isotretinoin 25 mg/1 | CapsuleOral | 69238-1256 | 69238-1256-03 | — |
| Isotretinoin | Isotretinoin 30 mg/1 | CapsuleOral | 69238-1257 | 69238-1257-03 | — |
| Isotretinoin | Isotretinoin 35 mg/1 | CapsuleOral | 69238-1258 | 69238-1258-03 | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 5 mg/mL | Injection, SolutionIntravenous | 70121-2428 | 70121-2428-03 | — |
| calcitonin salmon | Calcitonin salmon 200 [USP'U]/mL | Injection, SolutionIntramuscular, Subcutaneous | 70121-1650 | 70121-1650-02 | — |
| Sodium Oxybate | Sodium oxybate 500 mg/mL | SolutionOral | 65162-065 | 65162-0065-87 | — |
| Risperidone | — | KitIntramuscular | 70121-2627 | 70121-2627-05 | — |
| Risperidone | — | KitSubcutaneous | 70121-2625 | 70121-2625-05 | — |
| Risperidone | — | KitIntramuscular | 70121-2626 | 70121-2626-05 | — |
| Risperidone | — | KitIntramuscular | 70121-2628 | 70121-2628-05 | — |
| Fulvestrant | Fulvestrant 250 mg/5mL | Injection, SolutionIntramuscular | 70121-1463 | 70121-1463-09 | — |
| Brekiyadihydroergotamine mesylate | Dihydroergotamine mesylate 1 mg/mL | InjectionSubcutaneous | 64896-509 | 64896-0509-02 | — |
| Tepadinathiotepa | Thiotepa 400 mg/1 | Injection, Powder, Lyophilized, For solutionIntracavitary, Intravenous, Intravesical | 70121-1687 | 70121-1687-01 | — |
| Tepadinathiotepa | Thiotepa 200 mg/1 | Injection, Powder, Lyophilized, For solutionIntracavitary, Intravenous, Intravesical | 70121-2749 | 70121-2749-01 | — |
| Methylene blue | Methylene blue 5 mg/mL | Injection, SolutionIntravenous | 70121-2716 | 70121-2716-02 | — |
| Methylene blue | Methylene blue 5 mg/mL | Injection, SolutionIntravenous | 70121-2715 | 70121-2715-02 | — |
| Mesalamine | Mesalamine 800 mg/1 | Tablet, Delayed releaseOral | 65162-360 | 65162-0360-18 | — |
| Doxycycline | Doxycycline hyclate 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 70121-1616 | 70121-1616-07 | — |
| Exenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | 70121-1685 | 70121-1685-01 | — |
| Exenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | 70121-1686 | 70121-1686-01 | — |
| Pyridostigmine bromide | Pyridostigmine bromide 105 mg/1 | Tablet, Extended releaseOral | 60846-559 | 60846-0559-10 | — |
| Boruzubortezomib | Bortezomib 3.5 mg/1.4mL | InjectionIntravenous, Subcutaneous | 70121-2484 | 70121-2484-01 | — |
| Pitavastatin | Pitavastatin calcium 1 mg/1 | Tablet, Film coatedOral | 65162-029 | 65162-0029-0365162-0029-0965162-0029-50 | — |
| Pitavastatin | Pitavastatin calcium 2 mg/1 | Tablet, Film coatedOral | 65162-030 | 65162-0030-0365162-0030-0965162-0030-50 | — |
| Pitavastatin | Pitavastatin calcium 4 mg/1 | Tablet, Film coatedOral | 65162-031 | 65162-0031-0365162-0031-0965162-0031-50 | — |
| Crexontcarbidopa and levodopa | Carbidopa hydrate 52.5 mg/1; Levodopa 210 mg/1 | Capsule, Extended releaseOral | 64896-968 | 64896-0968-1664896-0968-23 | — |
| Crexontcarbidopa and levodopa | Carbidopa hydrate 35 mg/1; Levodopa 140 mg/1 | Capsule, Extended releaseOral | 64896-967 | 64896-0967-1664896-0967-23 | — |
| Crexontcarbidopa and levodopa | Carbidopa hydrate 70 mg/1; Levodopa 280 mg/1 | Capsule, Extended releaseOral | 64896-969 | 64896-0969-1664896-0969-23 | — |
| Crexontcarbidopa and levodopa | Carbidopa hydrate 87.5 mg/1; Levodopa 350 mg/1 | Capsule, Extended releaseOral | 64896-970 | 64896-0970-1664896-0970-23 | — |
| Potassium Phosphatespotassium phosphates in sodium chloride | Potassium phosphate, Monobasic 4.48 mg/mL; Potassium phosphate, Dibasic 4.72 mg/mL | InjectionIntravenous | 70121-1722 | 70121-1722-09 | — |
| calcium chloride | Calcium chloride 100 mg/mL | Injection, SolutionIntravenous | 70121-2309 | 70121-2309-07 | — |
| calcium chloride | Calcium chloride 100 mg/mL | Injection, SolutionIntravenous | 70121-2308 | 70121-2308-04 | — |
| Focinvezfosaprepitant dimeglumine | Fosaprepitant dimeglumine 150 mg/50mL | InjectionIntravenous | 70121-2631 | 70121-2631-01 | — |
| Naloxone Hydrochloride | Naloxone hydrochloride 4 mg/.1mL | SprayNasal | 69238-2104 | 69238-2104-07 | — |
| Ongentysopicapone | Opicapone 25 mg/1 | CapsuleOral | 64896-402 | 64896-0402-01 | — |
| Ongentysopicapone | Opicapone 50 mg/1 | CapsuleOral | 64896-403 | 64896-0403-0164896-0403-0264896-0403-03 | — |
| Foscarnet Sodium | Foscarnet sodium 24 mg/mL | InjectionIntravenous | 70121-1744 | 70121-1744-0270121-1744-07 | — |
| atropine sulfate | Atropine sulfate .1 mg/mL | Injection, SolutionIntravenous | 70121-1706 | 70121-1706-0270121-1706-04 | — |
Amneal Pharmaceuticals LLC: common questions
- What is Amneal Pharmaceuticals LLC's NDC labeler code?
- 60219, 60846, 64896, 65162, 69238, 70121. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Amneal Pharmaceuticals LLC?
- Med-Code's HCPCS directory matches J0897, J0171, J1040, J1050 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.